| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2018 | Feb 12, 2018 | MetaVia Inc. | CEO | Buy | 92.5 | +71,429 | 8.32% | ✗ | $500K |
| Jul 5, 2017 | Jul 6, 2017 | Rein Therapeutics, Inc. | 10% Owner | Buy | 92.5 | +60,000 | 6.28% | ✗ | $900K |
| Mar 10, 2017 | Mar 14, 2017 | MetaVia Inc. | Director | Buy | 92.5 | +52,798 | 6.55% | ✗ | $500K |
| Aug 10, 2016 | Aug 12, 2016 | MetaVia Inc. | Director | Buy | 100.0 | +500,000 | 163.39% | ✗ | $5M |